# Cora Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cora-therapeutics

- Industry: Food
- Headquarters: Toronto, Canada
- Website: www.coratherapeutics.com
- Total disclosed funding: $1M
- Latest round: Seed (Mar 27, 2023)
- Investors on record: 1

## About

Based in Ontario, Canada, and founded by Kieran Murphy (President and Chairman) in 2015, Cora Therapeutics, Inc. operates as a developer and manufacturer of research-based wellness solutions. In March 2023, the firm raised USD 1 million in seed funding led by investor IronGate Capital Advisors. The firm, as of March 2023, has 6 clinical papers published in collaboration with Dalhousie University, University of Toronto, and McMaster University, as well as 4 issued patents globally, and is led by its CEO, David Simpson.

The company manufactures and sells an antioxidant supplement, Halo Antioxidant, to aid in the prevention of oxidative stress-induced cellular, mitochondrial, and irreversible DNA damage caused or generated by medical imaging such as CT and X-Ray, and cosmic radiations which may lead to cardiovascular diseases, cancer, cataracts, and other conditions. Halo is a clinically proven, patented formulation and natural ingredients-based nutraceutical product.

The company plans to utilize its March 2023 funding to launch its product DNA Halo, to medical professionals, medical imaging patients, air travel professionals, frequent fliers, military personnel, and the health-conscious public, in North America.

## Funding rounds

- Seed, Mar 27, 2023, $1M — IronGate Capital Advisors

## Investors

- IronGate Capital Advisors — Seed